<DOC>
	<DOC>NCT02017548</DOC>
	<brief_summary>In a multicenter, randomized clinical trial of default options in advance directives among patients with incurable diseases, we will determine whether this simple and readily scalable intervention can improve patients quality of life and reduce resource utilization without reducing the number of days that patients are alive and living outside of an acute-care hospital.</brief_summary>
	<brief_title>Default Options in Advance Directives</brief_title>
	<detailed_description />
	<criteria>Age 18 or older Fluent in English Has seen current physician at least once prior to current visit Resident of Pennsylvania or New Jersey One or more of the following diagnoses: Amyotrophic lateral sclerosis Stage IIIB or IV nonsmall cell lung cancer, pancreatic cancer, or cholangiocarcinoma Stage IV breast, colon, esophageal, gastric, pancreatic, prostate, uterine, cervical, ovarian, or urothelial cancer; paraganglioma, or pheochromocytoma Stage C or D hepatocellular carcinoma Stage IV renal cell carcinoma Stage IV or V chronic kidney disease Mesothelioma or any malignancy metastatic to the pleura Other incurable interstitial lung diseases with at least severe restriction on most recent pulmonary function tests or eligible for longterm oxygen therapy Chronic obstructive pulmonary disease with at least severe airflow obstruction on most recent spirometry or eligible for longterm oxygen therapy Congestive heart failure with NYHA Class IV status or Class III plus 1 heart failure related hospitalization in the past 12 months or ACC stage D or C classification with 1 heart failure related hospitalization in the past 12 months Currently listed for or being considered for solid organ transplant Patients with a previously signed advance directive or living will.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>advance directives, advance care planning</keyword>
</DOC>